RALLYBIO CORPORATION (RLYB) EBITDA
RALLYBIO CORPORATION (RLYB) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$5.65M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$8.73M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$6.92M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$10.06M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$5.65M | (m) | (m) | (m) | (m) | $45.92M* | (m) | $758.00K | (m) | $1.32M |
|---|
| 2026-03-31 | Reported | (m) | -$8.73M | (m) | (m) | (m) | (m) | -$7.98M | (m) | $2.87M | (m) | (m) |
|---|
| 2025-09-30 | Reported | (m) | -$6.92M | (m) | (m) | (m) | (m) | -$6.55M* | (m) | $4.14M | (m) | (m) |
|---|
| 2025-06-30 | Reported | (m) | -$10.06M | (m) | (m) | (m) | (m) | -$8.38M* | (m) | $6.07M | (m) | $0.00 |
|---|
| 2025-03-31 | Reported | (m) | -$9.67M | (m) | (m) | (m) | (m) | -$10.21M | (m) | $5.72M | (m) | (m) |
|---|
| 2024-09-30 | Reported | (m) | -$12.07M | (m) | (m) | (m) | (m) | -$13.54M* | (m) | $8.24M | (m) | (m) |
|---|
| 2024-06-30 | Reported | (m) | -$17.04M | (m) | (m) | (m) | (m) | -$10.42M* | (m) | $12.95M | (m) | (m) |
|---|
| 2024-03-31 | Reported | (m) | -$19.79M | (m) | (m) | (m) | (m) | -$15.46M | (m) | $12.94M | (m) | (m) |
|---|
| 2023-09-30 | Reported | (m) | -$19.36M | (m) | (m) | (m) | $0.00* | -$16.47M* | (m) | $13.29M | (m) | (m) |
|---|
| 2023-06-30 | Reported | (m) | -$20.08M | (m) | (m) | (m) | $0.00* | -$13.38M* | (m) | $13.13M | (m) | (m) |
|---|
| 2023-03-31 | Reported | (m) | -$18.37M | (m) | (m) | (m) | $0.00 | -$18.77M | (m) | $11.20M | (m) | (m) |
|---|
| 2022-09-30 | Reported | (m) | -$18.86M | (m) | (m) | (m) | $4.00K* | -$14.73M* | (m) | $12.11M | (m) | (m) |
|---|
| 2022-06-30 | Reported | (m) | -$17.61M | (m) | (m) | (m) | $14.00K* | -$13.55M* | (m) | $10.14M | (m) | (m) |
|---|
| 2022-03-31 | Reported | (m) | -$14.32M | (m) | (m) | (m) | $36.00K | -$13.73M | (m) | $7.65M | (m) | (m) |
|---|
| 2021-09-30 | Reported | (m) | -$9.98M | (m) | (m) | (m) | $130.00K* | -$10.87M* | (m) | $4.96M | (m) | $0.00 |
|---|
| 2021-06-30 | Reported | (m) | -$10.53M | (m) | (m) | (m) | $4.00K* | -$12.85M* | (m) | $6.82M | (m) | $0.00 |
|---|
| 2021-03-31 | Reported | (m) | -$12.82M | (m) | (m) | (m) | $62.00K | -$11.93M | (m) | $9.04M | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$6.71M | (m) | (m) | (m) | $23.00K* | -$5.62M* | (m) | $5.13M | (m) | $0.00 |
|---|
| 2020-06-30 | Reported | (m) | -$4.66M | (m) | (m) | (m) | (m) | (m) | (m) | $3.09M | (m) | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$33.06M | (m) | (m) | (m) | (m) | -$29.81M | (m) | $19.60M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | (m) | -$60.50M | (m) | (m) | (m) | $0.00 | -$49.28M | (m) | $41.51M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | (m) | -$78.93M | (m) | (m) | (m) | $12.00K | -$60.27M | (m) | $53.54M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | (m) | -$67.88M | (m) | (m) | (m) | $54.00K | -$57.28M | (m) | $40.69M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | (m) | -$45.65M | (m) | (m) | (m) | $333.00K | -$45.53M | (m) | $26.91M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | (m) | -$25.30M | (m) | (m) | (m) | $137.00K | -$22.04M | (m) | $17.63M | (m) | -$15.00K |
|---|